UNSPSC 51391616: Milrinone lactate

This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H9N3O.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9K8XR81MO8, chemically known as 1,6-dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile but more generally known as milrinone lactate, which bears US NIH Compound Identifier 4197. European Medicines Agency schedules Milrinone lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14579MIG.

Most nations, for tariff and trade purposes, schedule milrinone lactate under HS 29337900 and SITC 51561. As of Q4 2014, MILRINONE LACTATE remains US FDA's Preferred Term for this commodity. Milrinone lactate bears US NLM identifiers UMLS ID C0699132 and NCI Concept Code C29263. SMILES: CC1C(CC(C(=O)[NH]1)C#N)C2CCNCC2.CC(C(=O)O)O.

UNSPSC 51391616 Milrinone lactate is a Commodity code that in practice covers pharmaceutical procurement by state and local health agencies, though recent activity under this code shows minimal direct alignment with the code's nominal scope. The two recent opportunities posted under this code involve naloxone and safe drug deactivation systems (Seminole County, Florida) and a market-research RFI on direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), neither of which specifically targets milrinone lactate or inotropic agents. Issuing bodies using this code include county health departments and state health commissions pursuing pharmaceutical acquisitions for community health and pharmacy benefit programs. The work being solicited reflects broader pharmaceutical procurement rather than the specific injectable inotrope named in the code.

Geographic activity centers on Florida and Texas based on recent postings. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor intelligence on direct-to-manufacturer prescription fulfillment models for self-insured health plans and state agencies outside traditional pharmacy benefit manager channels. The code shows sparse recent activity with material divergence between the nominal commodity and the solicitations actually posted under it, suggesting either inconsistent tagging or limited procurement volume in milrinone lactate specifically at the state and local level.